| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 2.26e-06 | 144 | 118 | 8 | GO:0016798 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing N-glycosyl compounds | 4.18e-06 | 41 | 118 | 5 | GO:0016799 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GPR4 GLRA3 CLEC1B TMEM63B TMEM63C GRIA1 GRIA2 TLR6 IL1RL2 GHR IGF2R PTPRB IL1RAPL2 IL17RE PTCH2 LRP6 ROS1 OR10J4 FGFR2 GRIN3B HCRTR1 HCRTR2 | 1.26e-05 | 1353 | 118 | 22 | GO:0004888 |
| GeneOntologyMolecularFunction | carbohydrate binding | CLEC18A MAN2A2 MAN2A1 GALM CLEC18B CLEC1B CLEC18C GALNT17 IGF2R MRC2 | 1.56e-05 | 310 | 118 | 10 | GO:0030246 |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity | 3.46e-05 | 2 | 118 | 2 | GO:0004572 | |
| GeneOntologyMolecularFunction | orexin receptor activity | 3.46e-05 | 2 | 118 | 2 | GO:0016499 | |
| GeneOntologyMolecularFunction | channel activity | RHCG GLRA3 TMEM63B TMEM63C GRIA1 GRIA2 KCNK16 TMC4 CLCN4 SCN4B SCN5A GRIN3B | 6.56e-05 | 525 | 118 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | RHCG GLRA3 TMEM63B TMEM63C GRIA1 GRIA2 KCNK16 TMC4 CLCN4 SCN4B SCN5A GRIN3B | 6.68e-05 | 526 | 118 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GLRA3 TMEM63B TMEM63C GRIA1 GRIA2 KCNK16 TMC4 CLCN4 SCN4B SCN5A GRIN3B | 8.83e-05 | 459 | 118 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | NAD+ nucleotidase, cyclic ADP-ribose generating | 1.07e-04 | 16 | 118 | 3 | GO:0061809 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 1.29e-04 | 17 | 118 | 3 | GO:0004970 | |
| GeneOntologyMolecularFunction | gated channel activity | 1.66e-04 | 334 | 118 | 9 | GO:0022836 | |
| GeneOntologyMolecularFunction | AMPA glutamate receptor activity | 2.06e-04 | 4 | 118 | 2 | GO:0004971 | |
| GeneOntologyMolecularFunction | osmolarity-sensing monoatomic cation channel activity | 3.42e-04 | 5 | 118 | 2 | GO:1990760 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 3.65e-04 | 103 | 118 | 5 | GO:0004553 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 3.72e-04 | 24 | 118 | 3 | GO:0099507 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity involved in cardiac muscle cell action potential | 5.11e-04 | 6 | 118 | 2 | GO:0086006 | |
| GeneOntologyMolecularFunction | N,N-dimethylaniline monooxygenase activity | 5.11e-04 | 6 | 118 | 2 | GO:0004499 | |
| GeneOntologyMolecularFunction | osmosensor activity | 5.11e-04 | 6 | 118 | 2 | GO:0005034 | |
| GeneOntologyMolecularFunction | glutamate receptor activity | 5.31e-04 | 27 | 118 | 3 | GO:0008066 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 5.94e-04 | 65 | 118 | 4 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 5.94e-04 | 65 | 118 | 4 | GO:0022824 | |
| GeneOntologyMolecularFunction | polysaccharide binding | 8.01e-04 | 31 | 118 | 3 | GO:0030247 | |
| GeneOntologyMolecularFunction | interleukin-1 receptor activity | 9.47e-04 | 8 | 118 | 2 | GO:0004908 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 9.94e-04 | 343 | 118 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.01e-03 | 193 | 118 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 1.12e-03 | 77 | 118 | 4 | GO:0005230 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.13e-03 | 197 | 118 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | phosphorylation-dependent protein binding | 1.51e-03 | 10 | 118 | 2 | GO:0140031 | |
| GeneOntologyMolecularFunction | mannosyl-oligosaccharide mannosidase activity | 1.51e-03 | 10 | 118 | 2 | GO:0015924 | |
| GeneOntologyMolecularFunction | amide binding | 2.01e-03 | 299 | 118 | 7 | GO:0033218 | |
| GeneOntologyMolecularFunction | NAD+ nucleosidase activity | 2.20e-03 | 12 | 118 | 2 | GO:0003953 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 2.63e-03 | 97 | 118 | 4 | GO:0004896 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 2.94e-03 | 100 | 118 | 4 | GO:0030594 | |
| GeneOntologyMolecularFunction | glycine binding | 3.01e-03 | 14 | 118 | 2 | GO:0016594 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 3.15e-03 | 102 | 118 | 4 | GO:0001540 | |
| GeneOntologyMolecularFunction | alpha-mannosidase activity | 3.46e-03 | 15 | 118 | 2 | GO:0004559 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 3.50e-03 | 105 | 118 | 4 | GO:0015171 | |
| GeneOntologyMolecularFunction | sodium channel activity | 3.60e-03 | 52 | 118 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | transporter activity | RHCG GLRA3 TMEM63B TMEM63C GRIA1 GRIA2 KCNK16 TMC4 XKR4 SLC3A1 CLCN4 MFSD14B SCN4B SCN5A LRP6 GRIN3B | 3.79e-03 | 1289 | 118 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 3.94e-03 | 16 | 118 | 2 | GO:0005041 | |
| GeneOntologyMolecularFunction | mannosidase activity | 3.94e-03 | 16 | 118 | 2 | GO:0015923 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | RHCG GLRA3 TMEM63B TMEM63C GRIA1 GRIA2 KCNK16 TMC4 SLC3A1 CLCN4 MFSD14B SCN4B SCN5A LRP6 GRIN3B | 4.06e-03 | 1180 | 118 | 15 | GO:0022857 |
| GeneOntologyMolecularFunction | peptide hormone binding | 4.22e-03 | 55 | 118 | 3 | GO:0017046 | |
| GeneOntologyMolecularFunction | calcium-dependent cysteine-type endopeptidase activity | 4.44e-03 | 17 | 118 | 2 | GO:0004198 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 4.67e-03 | 57 | 118 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 4.98e-03 | 18 | 118 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | RHCG GLRA3 TMEM63B TMEM63C GRIA1 GRIA2 KCNK16 CLCN4 SCN4B SCN5A GRIN3B | 5.28e-03 | 758 | 118 | 11 | GO:0015318 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 5.39e-03 | 60 | 118 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | RHCG WIPF1 ANK3 CAPN2 LRRK2 GRIA1 GRIA2 PSTPIP1 ACE TAOK2 TUBGCP3 SCN5A KIF14 AFDN | 5.39e-03 | 1099 | 118 | 14 | GO:0008092 |
| GeneOntologyMolecularFunction | mitogen-activated protein kinase kinase binding | 5.54e-03 | 19 | 118 | 2 | GO:0031434 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 6.13e-03 | 123 | 118 | 4 | GO:0030165 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 6.14e-03 | 20 | 118 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | translation elongation factor activity | 6.14e-03 | 20 | 118 | 2 | GO:0003746 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 6.73e-03 | 65 | 118 | 3 | GO:0004714 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 6.76e-03 | 21 | 118 | 2 | GO:0030228 | |
| GeneOntologyBiologicalProcess | endocytosis | ANK3 CAPN2 LRRK2 GRIA1 GRIA2 PSTPIP1 XKR4 GHR IGF2R PIK3CA MRC2 LRP1 LRP6 FER1L5 RAB5A RAB5B | 1.41e-05 | 827 | 115 | 16 | GO:0006897 |
| GeneOntologyCellularComponent | cell surface | ANK3 CAPN2 CLEC1B TSPEAR GRIA1 GRIA2 ACE PTGFRN GHR IGF2R MRC2 ENTPD6 SCN5A LRP1 LRP6 ROS1 FGFR2 | 1.34e-04 | 1111 | 116 | 17 | GO:0009986 |
| GeneOntologyCellularComponent | cell-cell contact zone | 1.79e-04 | 94 | 116 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | perisynaptic space | 1.82e-04 | 4 | 116 | 2 | GO:0099544 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | 4.94e-04 | 179 | 116 | 6 | GO:0099501 | |
| GeneOntologyCellularComponent | synaptic vesicle membrane | 4.94e-04 | 179 | 116 | 6 | GO:0030672 | |
| GeneOntologyCellularComponent | intercalated disc | 5.58e-04 | 68 | 116 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 9.06e-04 | 201 | 116 | 6 | GO:0099634 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 9.36e-04 | 78 | 116 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | anchoring junction | ANK3 CAPN2 GRIA1 MFRP NPHP4 IGF2R PIK3CA MRC2 LMLN SCN4B SCN5A LRP1 AFDN PLCG1 | 1.03e-03 | 976 | 116 | 14 | GO:0070161 |
| GeneOntologyCellularComponent | early endosome membrane | 1.19e-03 | 212 | 116 | 6 | GO:0031901 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 1.19e-03 | 212 | 116 | 6 | GO:0030666 | |
| GeneOntologyCellularComponent | endocytic vesicle | 1.37e-03 | 384 | 116 | 8 | GO:0030139 | |
| GeneOntologyCellularComponent | synaptic vesicle | 1.44e-03 | 300 | 116 | 7 | GO:0008021 | |
| GeneOntologyCellularComponent | receptor complex | 1.49e-03 | 581 | 116 | 10 | GO:0043235 | |
| GeneOntologyCellularComponent | postsynaptic endocytic zone | 1.63e-03 | 11 | 116 | 2 | GO:0098843 | |
| GeneOntologyCellularComponent | vacuole | GPLD1 NEU4 ANK3 CAPN2 LRRK2 GLB1L2 ACE SLC3A1 CLCN4 WDR11 LRP1 DEPDC5 SESN2 | 1.67e-03 | 913 | 116 | 13 | GO:0005773 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 1.84e-03 | 157 | 116 | 5 | GO:0098839 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.91e-03 | 405 | 116 | 8 | GO:0045211 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 1.99e-03 | 45 | 116 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | terminal bouton | 2.02e-03 | 96 | 116 | 4 | GO:0043195 | |
| GeneOntologyCellularComponent | exocytic vesicle | 2.07e-03 | 320 | 116 | 7 | GO:0070382 | |
| GeneOntologyCellularComponent | transport vesicle | 2.44e-03 | 519 | 116 | 9 | GO:0030133 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 2.70e-03 | 50 | 116 | 3 | GO:0098878 | |
| GeneOntologyCellularComponent | excitatory synapse | 2.99e-03 | 107 | 116 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CALB1 ANK3 CAPN2 LRRK2 GLRA3 GRIA1 GRIA2 TAOK2 GHR LRP1 CNTNAP4 LRP6 AFDN GRIN3B RAB5A | 3.26e-03 | 1228 | 116 | 15 | GO:0036477 |
| GeneOntologyCellularComponent | Wnt signalosome | 3.48e-03 | 16 | 116 | 2 | GO:1990909 | |
| GeneOntologyCellularComponent | Seh1-associated complex | 3.48e-03 | 16 | 116 | 2 | GO:0035859 | |
| GeneOntologyCellularComponent | ciliary base | 3.73e-03 | 56 | 116 | 3 | GO:0097546 | |
| GeneOntologyCellularComponent | presynapse | CALB1 LRRK2 GLRA3 GRIA1 GRIA2 CLCN4 CNTNAP4 AFDN GRIN3B FER1L5 RAB5A RAB5B | 3.77e-03 | 886 | 116 | 12 | GO:0098793 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.93e-03 | 17 | 116 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | lipid droplet | 4.00e-03 | 116 | 116 | 4 | GO:0005811 | |
| Domain | Orexin_rcpt | 3.69e-05 | 2 | 114 | 2 | IPR000204 | |
| Domain | CAP | 9.55e-05 | 15 | 114 | 3 | PF00188 | |
| Domain | SCP | 9.55e-05 | 15 | 114 | 3 | SM00198 | |
| Domain | Allrgn_V5/Tpx1 | 9.55e-05 | 15 | 114 | 3 | IPR001283 | |
| Domain | LY | 9.55e-05 | 15 | 114 | 3 | SM00135 | |
| Domain | - | 9.55e-05 | 15 | 114 | 3 | 3.40.33.10 | |
| Domain | CAP_domain | 9.55e-05 | 15 | 114 | 3 | IPR014044 | |
| Domain | LDLR_classB_rpt | 9.55e-05 | 15 | 114 | 3 | IPR000033 | |
| Domain | RSN1_7TM | 1.10e-04 | 3 | 114 | 2 | IPR003864 | |
| Domain | PHM7_cyt | 1.10e-04 | 3 | 114 | 2 | IPR027815 | |
| Domain | RSN1_TM | 1.10e-04 | 3 | 114 | 2 | PF13967 | |
| Domain | PHM7_cyt | 1.10e-04 | 3 | 114 | 2 | PF14703 | |
| Domain | RSN1_7TM | 1.10e-04 | 3 | 114 | 2 | PF02714 | |
| Domain | Csc1_N | 1.10e-04 | 3 | 114 | 2 | IPR032880 | |
| Domain | C_TYPE_LECTIN_1 | 1.30e-04 | 80 | 114 | 5 | PS00615 | |
| Domain | C-type_lectin_CS | 1.35e-04 | 43 | 114 | 4 | IPR018378 | |
| Domain | Gal_mutarotase_SF_dom | 1.41e-04 | 17 | 114 | 3 | IPR011013 | |
| Domain | Lectin_C | 1.63e-04 | 84 | 114 | 5 | PF00059 | |
| Domain | CLECT | 1.63e-04 | 84 | 114 | 5 | SM00034 | |
| Domain | Lig_chan-Glu_bd | 1.69e-04 | 18 | 114 | 3 | PF10613 | |
| Domain | Glu/Gly-bd | 1.69e-04 | 18 | 114 | 3 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 1.69e-04 | 18 | 114 | 3 | SM00918 | |
| Domain | Iontro_rcpt | 1.69e-04 | 18 | 114 | 3 | IPR001320 | |
| Domain | Iono_rcpt_met | 1.69e-04 | 18 | 114 | 3 | IPR001508 | |
| Domain | Lig_chan | 1.69e-04 | 18 | 114 | 3 | PF00060 | |
| Domain | PBPe | 1.69e-04 | 18 | 114 | 3 | SM00079 | |
| Domain | C_TYPE_LECTIN_2 | 1.72e-04 | 85 | 114 | 5 | PS50041 | |
| Domain | C-type_lectin-like | 1.82e-04 | 86 | 114 | 5 | IPR001304 | |
| Domain | TIR | 2.72e-04 | 21 | 114 | 3 | SM00255 | |
| Domain | TIR | 3.13e-04 | 22 | 114 | 3 | PF01582 | |
| Domain | - | 3.20e-04 | 97 | 114 | 5 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 3.51e-04 | 99 | 114 | 5 | IPR016186 | |
| Domain | - | 3.59e-04 | 23 | 114 | 3 | 3.40.50.10140 | |
| Domain | Glyco_hydro_38_C | 3.65e-04 | 5 | 114 | 2 | IPR011682 | |
| Domain | Alpha-mann_mid | 3.65e-04 | 5 | 114 | 2 | PF09261 | |
| Domain | Glyco_hydro_57/38_cen | 3.65e-04 | 5 | 114 | 2 | IPR028995 | |
| Domain | Glyco_hydro_38 | 3.65e-04 | 5 | 114 | 2 | PF01074 | |
| Domain | - | 3.65e-04 | 5 | 114 | 2 | 1.20.1270.50 | |
| Domain | - | 3.65e-04 | 5 | 114 | 2 | 3.20.110.10 | |
| Domain | Alpha-mann_mid | 3.65e-04 | 5 | 114 | 2 | SM00872 | |
| Domain | Glyco_hydro_38_N | 3.65e-04 | 5 | 114 | 2 | IPR000602 | |
| Domain | Glyco_hydro_38/57_N | 3.65e-04 | 5 | 114 | 2 | IPR027291 | |
| Domain | Glyco_hydro_38_cen | 3.65e-04 | 5 | 114 | 2 | IPR015341 | |
| Domain | Glyco_hydro_38C | 3.65e-04 | 5 | 114 | 2 | PF07748 | |
| Domain | TIR | 4.08e-04 | 24 | 114 | 3 | PS50104 | |
| Domain | TIR_dom | 4.62e-04 | 25 | 114 | 3 | IPR000157 | |
| Domain | CTDL_fold | 5.03e-04 | 107 | 114 | 5 | IPR016187 | |
| Domain | Glyco_hydro/deAcase_b/a-brl | 7.60e-04 | 7 | 114 | 2 | IPR011330 | |
| Domain | Man6P_isomerase_rcpt-bd_dom | 1.01e-03 | 8 | 114 | 2 | IPR009011 | |
| Domain | MBT | 1.29e-03 | 9 | 114 | 2 | SM00561 | |
| Domain | MBT | 1.29e-03 | 9 | 114 | 2 | PS51079 | |
| Domain | MBT | 1.61e-03 | 10 | 114 | 2 | PF02820 | |
| Domain | Mbt | 1.61e-03 | 10 | 114 | 2 | IPR004092 | |
| Domain | Peripla_BP_I | 1.72e-03 | 39 | 114 | 3 | IPR028082 | |
| Domain | - | 1.72e-03 | 39 | 114 | 3 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 1.86e-03 | 40 | 114 | 3 | IPR023415 | |
| Domain | IL-1_rcpt_fam | 1.96e-03 | 11 | 114 | 2 | IPR015621 | |
| Domain | Ldl_recept_a | 2.61e-03 | 45 | 114 | 3 | PF00057 | |
| Domain | - | 2.76e-03 | 13 | 114 | 2 | 2.10.10.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.78e-03 | 46 | 114 | 3 | IPR011042 | |
| Domain | - | 2.78e-03 | 46 | 114 | 3 | 4.10.400.10 | |
| Domain | LDLRA_1 | 3.14e-03 | 48 | 114 | 3 | PS01209 | |
| Domain | FN_type2_col-bd | 3.20e-03 | 14 | 114 | 2 | IPR000562 | |
| Domain | FN2_2 | 3.20e-03 | 14 | 114 | 2 | PS51092 | |
| Domain | FN2_1 | 3.20e-03 | 14 | 114 | 2 | PS00023 | |
| Domain | - | 3.20e-03 | 14 | 114 | 2 | 2.60.40.1180 | |
| Domain | Ldl_recept_b | 3.20e-03 | 14 | 114 | 2 | PF00058 | |
| Domain | LDLRB | 3.20e-03 | 14 | 114 | 2 | PS51120 | |
| Domain | fn2 | 3.20e-03 | 14 | 114 | 2 | PF00040 | |
| Domain | FN2 | 3.20e-03 | 14 | 114 | 2 | SM00059 | |
| Domain | EGF | 3.21e-03 | 235 | 114 | 6 | SM00181 | |
| Domain | EGF_3 | 3.21e-03 | 235 | 114 | 6 | PS50026 | |
| Domain | LDrepeatLR_classA_rpt | 3.33e-03 | 49 | 114 | 3 | IPR002172 | |
| Domain | LDLa | 3.33e-03 | 49 | 114 | 3 | SM00192 | |
| Domain | LDLRA_2 | 3.33e-03 | 49 | 114 | 3 | PS50068 | |
| Domain | Peptidase_C2 | 3.68e-03 | 15 | 114 | 2 | PF00648 | |
| Domain | CysPc | 3.68e-03 | 15 | 114 | 2 | SM00230 | |
| Domain | Glyco_hydro_b | 3.68e-03 | 15 | 114 | 2 | IPR013780 | |
| Domain | Peptidase_C2_calpain_cat | 3.68e-03 | 15 | 114 | 2 | IPR001300 | |
| Domain | CALPAIN_CAT | 3.68e-03 | 15 | 114 | 2 | PS50203 | |
| Domain | EGF-like_dom | 4.26e-03 | 249 | 114 | 6 | IPR000742 | |
| Domain | NAP_family | 4.73e-03 | 17 | 114 | 2 | IPR002164 | |
| Domain | NAP | 4.73e-03 | 17 | 114 | 2 | PF00956 | |
| Domain | EGF_1 | 4.78e-03 | 255 | 114 | 6 | PS00022 | |
| Domain | EGF-like_CS | 5.34e-03 | 261 | 114 | 6 | IPR013032 | |
| Domain | EGF_2 | 5.74e-03 | 265 | 114 | 6 | PS01186 | |
| Pubmed | Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity. | 3.81e-08 | 3 | 118 | 3 | 26170455 | |
| Pubmed | 3.81e-08 | 3 | 118 | 3 | 16336259 | ||
| Pubmed | Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection. | 3.81e-08 | 3 | 118 | 3 | 33603190 | |
| Pubmed | 1.52e-07 | 4 | 118 | 3 | 16709836 | ||
| Pubmed | 1.52e-07 | 4 | 118 | 3 | 15978554 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | USP34 TRIML2 NPHP4 SLC3A1 PPM1B EEF1G PTPRB IL1RAPL2 LRP1 SESN2 FGFR2 | 2.10e-07 | 420 | 118 | 11 | 28065597 |
| Pubmed | 2.11e-06 | 8 | 118 | 3 | 14602821 | ||
| Pubmed | Lacrimal gland budding requires PI3K-dependent suppression of EGF signaling. | 4.21e-06 | 32 | 118 | 4 | 34193412 | |
| Pubmed | 4.49e-06 | 10 | 118 | 3 | 26355680 | ||
| Pubmed | 7.63e-06 | 37 | 118 | 4 | 22432025 | ||
| Pubmed | Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice. | 8.19e-06 | 12 | 118 | 3 | 30175250 | |
| Pubmed | 1.06e-05 | 13 | 118 | 3 | 16814779 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 34475397 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 27237973 | ||
| Pubmed | Peripheral calcium-permeable AMPA receptors regulate chronic inflammatory pain in mice. | 1.14e-05 | 2 | 118 | 2 | 21383497 | |
| Pubmed | Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors. | 1.14e-05 | 2 | 118 | 2 | 26950369 | |
| Pubmed | Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships. | 1.14e-05 | 2 | 118 | 2 | 7999363 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22389503 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 37640963 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 14555717 | ||
| Pubmed | Anxiolytic function of the orexin 2/hypocretin A receptor in the basolateral amygdala. | 1.14e-05 | 2 | 118 | 2 | 24485472 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 15541312 | ||
| Pubmed | Synaptic AMPA receptor exchange maintains bidirectional plasticity. | 1.14e-05 | 2 | 118 | 2 | 16600857 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 28725178 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 8524845 | ||
| Pubmed | Angiogenesis-related gene mutations drive a subset of angiosarcomas. | 1.14e-05 | 2 | 118 | 2 | 24795022 | |
| Pubmed | New insights in endosomal dynamics and AMPA receptor trafficking. | 1.14e-05 | 2 | 118 | 2 | 21843653 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 15619119 | ||
| Pubmed | Comment on "Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2". | 1.14e-05 | 2 | 118 | 2 | 26582896 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 27314038 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 33008707 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 31053408 | ||
| Pubmed | Association of orexin receptor polymorphisms with antipsychotic-induced weight gain. | 1.14e-05 | 2 | 118 | 2 | 26447462 | |
| Pubmed | Genetic mapping of the Rab5a and Rab5b genes on mouse Chromosomes 17 and 2, respectively. | 1.14e-05 | 2 | 118 | 2 | 8835543 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 20576035 | ||
| Pubmed | GluA2-lacking AMPA receptors in hippocampal CA1 cell synapses: evidence from gene-targeted mice. | 1.14e-05 | 2 | 118 | 2 | 22375105 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 29230056 | ||
| Pubmed | Orexin 1 and 2 Receptors in the Prelimbic Cortex Modulate Threat Valuation. | 1.14e-05 | 2 | 118 | 2 | 34126185 | |
| Pubmed | An early endosome regulator, Rab5b, is an LRRK2 kinase substrate. | 1.14e-05 | 2 | 118 | 2 | 25605758 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 27988352 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 16754854 | ||
| Pubmed | Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk. | 1.14e-05 | 2 | 118 | 2 | 26031789 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 22770842 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 25500815 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 30146304 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 21510948 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 19746427 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 18445495 | ||
| Pubmed | FGFR2 and WDR11 are neighboring oncogene and tumor suppressor gene on human chromosome 10q26. | 1.14e-05 | 2 | 118 | 2 | 12684685 | |
| Pubmed | Recombination cluster around FGFR2-WDR11-HTPAPL locus on human chromosome 10q26. | 1.14e-05 | 2 | 118 | 2 | 12684693 | |
| Pubmed | Polymorphisms in hypocretin/orexin pathway genes and narcolepsy. | 1.14e-05 | 2 | 118 | 2 | 11723285 | |
| Pubmed | A voltage-gated sodium channel is essential for the positive selection of CD4(+) T cells. | 1.14e-05 | 2 | 118 | 2 | 22842345 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 14573529 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 24633157 | ||
| Pubmed | AMPA receptor regulation during synaptic plasticity in hippocampus and neocortex. | 1.14e-05 | 2 | 118 | 2 | 21856433 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 1311100 | ||
| Pubmed | Cellular localization of orexin receptors in human pituitary. | 1.14e-05 | 2 | 118 | 2 | 11443222 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 1699805 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 34924114 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 15256537 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 7502080 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 15797953 | ||
| Pubmed | Peripherally administered orexin improves survival of mice with endotoxin shock. | 1.14e-05 | 2 | 118 | 2 | 28035899 | |
| Pubmed | Cortical Synaptic AMPA Receptor Plasticity during Motor Learning. | 1.14e-05 | 2 | 118 | 2 | 31901303 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 38199807 | ||
| Pubmed | SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome. | 1.14e-05 | 2 | 118 | 2 | 17592081 | |
| Pubmed | Hcrtr1 and 2 signaling differentially regulates depression-like behaviors. | 1.14e-05 | 2 | 118 | 2 | 21377495 | |
| Pubmed | AMPA glutamate receptors and their flip and flop mRNAs in human hippocampus. | 1.14e-05 | 2 | 118 | 2 | 7919190 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 18714784 | ||
| Pubmed | N-Glycan structure analysis using lectins and an alpha-mannosidase activity assay. | 1.14e-05 | 2 | 118 | 2 | 17113875 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 23475111 | ||
| Pubmed | Protective LRRK2 R1398H Variant Enhances GTPase and Wnt Signaling Activity. | 1.14e-05 | 2 | 118 | 2 | 27013965 | |
| Pubmed | Expression of alternatively-spliced glutamate receptors in human hippocampus. | 1.14e-05 | 2 | 118 | 2 | 8420792 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 27683906 | ||
| Pubmed | Germ cell survival through carbohydrate-mediated interaction with Sertoli cells. | 1.14e-05 | 2 | 118 | 2 | 11778047 | |
| Pubmed | Cholinergic modulation of narcoleptic attacks in double orexin receptor knockout mice. | 1.14e-05 | 2 | 118 | 2 | 21533254 | |
| Pubmed | Panic disorder is associated with the Val308Iso polymorphism in the hypocretin receptor gene. | 1.14e-05 | 2 | 118 | 2 | 21666548 | |
| Pubmed | Interplay between FGFR2b-induced autophagy and phagocytosis: role of PLCγ-mediated signalling. | 1.14e-05 | 2 | 118 | 2 | 28994193 | |
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 28336441 | ||
| Pubmed | 1.14e-05 | 2 | 118 | 2 | 26996108 | ||
| Pubmed | 2.06e-05 | 16 | 118 | 3 | 15240797 | ||
| Pubmed | 2.50e-05 | 17 | 118 | 3 | 26389685 | ||
| Pubmed | 2.50e-05 | 17 | 118 | 3 | 32185508 | ||
| Pubmed | 2.99e-05 | 18 | 118 | 3 | 12588844 | ||
| Pubmed | 2.99e-05 | 18 | 118 | 3 | 14730302 | ||
| Pubmed | Haptoglobin phenotype and the risk of restenosis after coronary artery stent implantation. | 3.42e-05 | 3 | 118 | 2 | 11909563 | |
| Pubmed | Sestrins inhibit mTORC1 kinase activation through the GATOR complex. | 3.42e-05 | 3 | 118 | 2 | 25457612 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 9491897 | ||
| Pubmed | Obesity and the hypothalamus: novel peptides for new pathways. | 3.42e-05 | 3 | 118 | 2 | 9491885 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 27045885 | ||
| Pubmed | FXR1P limits long-term memory, long-lasting synaptic potentiation, and de novo GluA2 translation. | 3.42e-05 | 3 | 118 | 2 | 25456134 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 34426577 | ||
| Pubmed | Competition between Grb2 and Plcγ1 for FGFR2 regulates basal phospholipase activity and invasion. | 3.42e-05 | 3 | 118 | 2 | 24440983 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 11340621 | ||
| Pubmed | Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep. | 3.42e-05 | 3 | 118 | 2 | 21525292 | |
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 27348297 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 15144856 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 26687682 | ||
| Pubmed | 3.42e-05 | 3 | 118 | 2 | 12700243 | ||
| Pubmed | Ras and Rap Signal Bidirectional Synaptic Plasticity via Distinct Subcellular Microdomains. | 3.42e-05 | 3 | 118 | 2 | 29706584 | |
| Interaction | VIL1 interactions | 1.12e-05 | 25 | 114 | 4 | int:VIL1 | |
| Interaction | GRIN2A interactions | 1.47e-05 | 93 | 114 | 6 | int:GRIN2A | |
| Interaction | PHLDB2 interactions | 1.71e-05 | 143 | 114 | 7 | int:PHLDB2 | |
| GeneFamily | C-type lectin domain family | 1.44e-06 | 47 | 75 | 5 | 494 | |
| GeneFamily | Hypocretin receptors | 1.70e-05 | 2 | 75 | 2 | 228 | |
| GeneFamily | Glutamate ionotropic receptor AMPA type subunits | 1.01e-04 | 4 | 75 | 2 | 1200 | |
| GeneFamily | Mannosidases alpha class 2 | 1.68e-04 | 5 | 75 | 2 | 1194 | |
| GeneFamily | Sterile alpha motif domain containing|MBT domain containing | 6.00e-04 | 9 | 75 | 2 | 1263 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 7.01e-04 | 42 | 75 | 3 | 602 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.23e-03 | 394 | 75 | 7 | 471 | |
| GeneFamily | Low density lipoprotein receptors | 1.29e-03 | 13 | 75 | 2 | 634 | |
| GeneFamily | C2 domain containing|Calpains | 1.72e-03 | 15 | 75 | 2 | 975 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 1.72e-03 | 15 | 75 | 2 | 1296 | |
| GeneFamily | WD repeat domain containing|DDB1 and CUL4 associated factors | 2.49e-03 | 18 | 75 | 2 | 498 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 3.39e-03 | 21 | 75 | 2 | 89 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-08 | 165 | 118 | 8 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-08 | 165 | 118 | 8 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-07 | 184 | 118 | 7 | ab2f06906fc7a9931dfa0864ef506832b07fb93e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.75e-07 | 194 | 118 | 7 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | proximal-Epithelial-Signaling_Alveolar_Epithelial_Type_2-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.07e-06 | 200 | 118 | 7 | 7bd76884fcffdbd9b8d24f5b6b5187ad3963da5f | |
| ToppCell | proximal-Epithelial-Signaling_Alveolar_Epithelial_Type_2|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.07e-06 | 200 | 118 | 7 | af57f837eb7f988d24fc4612d16d68121498f0b0 | |
| ToppCell | proximal-3-Epithelial-Signaling_Alveolar_Epithelial_Type_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.07e-06 | 200 | 118 | 7 | 9c7859659843b1566bdf623b269b5e166c89d38c | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.92e-06 | 157 | 118 | 6 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.40e-06 | 166 | 118 | 6 | 1df4bdf7c773cbfa6c93d7a901f9cd3f3fe07a3d | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Club_cells-Airway|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.40e-06 | 166 | 118 | 6 | 9628522e7af8f8edca733588a364ab2454ac5ca5 | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.98e-06 | 169 | 118 | 6 | d382a76d85875663502cc7dde2e3e0682605768e | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-06 | 174 | 118 | 6 | f0974f4e94a9719f9b96820e70c23b6c6c0f02fe | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.31e-06 | 179 | 118 | 6 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 9.13e-06 | 182 | 118 | 6 | 0c77ef4556c1d1512ebe9077df858b28f9e38dd5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.42e-06 | 183 | 118 | 6 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.72e-06 | 184 | 118 | 6 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.72e-06 | 184 | 118 | 6 | 2a8338e94937686a148b5433515700ca0f674058 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.00e-05 | 185 | 118 | 6 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.00e-05 | 185 | 118 | 6 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 1.00e-05 | 185 | 118 | 6 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.00e-05 | 185 | 118 | 6 | 602536a3308a848f106adcb0a83530997440c8f4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.00e-05 | 185 | 118 | 6 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.03e-05 | 186 | 118 | 6 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-05 | 186 | 118 | 6 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.07e-05 | 187 | 118 | 6 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 1.13e-05 | 189 | 118 | 6 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.17e-05 | 190 | 118 | 6 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.17e-05 | 190 | 118 | 6 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-05 | 191 | 118 | 6 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.20e-05 | 191 | 118 | 6 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | 367C-Epithelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-05 | 191 | 118 | 6 | d31975fc33779b0b3ff1a50d7c64fec8d08be4d4 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 1.20e-05 | 191 | 118 | 6 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.20e-05 | 191 | 118 | 6 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 1.20e-05 | 191 | 118 | 6 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.20e-05 | 191 | 118 | 6 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 1.24e-05 | 192 | 118 | 6 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.24e-05 | 192 | 118 | 6 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.27e-05 | 193 | 118 | 6 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | NS-critical-d_0-4-Epithelial-Basal|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.27e-05 | 193 | 118 | 6 | 1affb4c2e21712bde0d36ab736411fe36642cc6d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 1.27e-05 | 193 | 118 | 6 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.27e-05 | 193 | 118 | 6 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-05 | 194 | 118 | 6 | cb0422e7607dbd77204428b7e2c70dfe14a6ca11 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.39e-05 | 196 | 118 | 6 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.43e-05 | 197 | 118 | 6 | 44a59dfb889577b3160a5b13ada1276771a00241 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.43e-05 | 197 | 118 | 6 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.47e-05 | 198 | 118 | 6 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.52e-05 | 199 | 118 | 6 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.52e-05 | 199 | 118 | 6 | 2dc33804f6691d7c9682e6c9b885e945fb97fc36 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.56e-05 | 200 | 118 | 6 | e8db082aa4d0597500e4f16a5c0ea3e62c6c59ae | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.56e-05 | 200 | 118 | 6 | 3c251ad03fbbdae91dfd9037880ba43adbb03807 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.56e-05 | 200 | 118 | 6 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.56e-05 | 200 | 118 | 6 | c905451425d1c24773bb0ca69bcf0309b277d2f1 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.56e-05 | 200 | 118 | 6 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.56e-05 | 200 | 118 | 6 | 35c05cae30cd6b323d2662f1396ddeab08bc75fc | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.56e-05 | 200 | 118 | 6 | 9970e9bde6aa2ff3aef60dcb065ff15b7463e147 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.56e-05 | 200 | 118 | 6 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-05 | 141 | 118 | 5 | 4aa4b3476dc5abefbd348353cfe711cd5fe3d52f | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.71e-05 | 141 | 118 | 5 | e40c6f1b7fbaa46b3eaa55f1b37ef360b04370a8 | |
| ToppCell | facs-Heart-Unknown-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.83e-05 | 142 | 118 | 5 | 759fbbd15b4fb313bd6269b7f087edafebd530ef | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.30e-05 | 152 | 118 | 5 | 82a493ffb2f1704cd6f68a82d970fe12f537d20e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.64e-05 | 154 | 118 | 5 | 30cb4bb297fa815adb829f3b5cafca56fcbcb810 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.64e-05 | 154 | 118 | 5 | ade094e2947761a0a34daa8fcff3e9ea8437e4a5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.64e-05 | 154 | 118 | 5 | 42bd8f88fd075a2d4edde394785decad88a2660a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.64e-05 | 154 | 118 | 5 | 6425d9861148586466febd6eceae1b1f9b9a14c1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.76e-05 | 160 | 118 | 5 | 0bfdaf979e6f128cba2928ce16bca4d3deff8ac9 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-1|TCGA-Kidney / Sample_Type by Project: Shred V9 | 6.96e-05 | 161 | 118 | 5 | 6cacae4a759ace763597ee394cff498dc5d96f74 | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 6.96e-05 | 161 | 118 | 5 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.60e-05 | 164 | 118 | 5 | beaa13a75c3bb72446c85084d75e9fe3f15fd3d4 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.60e-05 | 164 | 118 | 5 | d005cfd821b87548b075120bffe65a0be9860463 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 7.82e-05 | 165 | 118 | 5 | 9795ce31689bc63f5a2d68725ef00b23a90c3846 | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 7.82e-05 | 165 | 118 | 5 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-05 | 166 | 118 | 5 | 5126d8f02314717eed341d867856fd4fe16c5118 | |
| ToppCell | facs-Lung-Endomucin-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.05e-05 | 166 | 118 | 5 | 3037bdca38c3a65eacfa644219cc43c54e303749 | |
| ToppCell | facs-Trachea-nan-24m-Mesenchymal-smooth_muscle_cell_of_trachea|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.51e-05 | 168 | 118 | 5 | 6c7b490b6c844d0ea4c07edfc24c02284f9533c4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_CMAHP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.00e-05 | 170 | 118 | 5 | 49fc45d8a5c3ad89d1649fa46d7a285891379392 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.77e-05 | 173 | 118 | 5 | af85fb9f6e26a044ca4d23e5872039b1a7b73b1b | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 9.77e-05 | 173 | 118 | 5 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.77e-05 | 173 | 118 | 5 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 91 | 118 | 4 | b0658e020f80e56fab9d2aa07e321d9b33d7af2c | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.03e-04 | 175 | 118 | 5 | 8a4ed775ff973123dbcfe9c809959d11a62450c9 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 175 | 118 | 5 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Endothelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 176 | 118 | 5 | 27e5115fae5f0f63b333bc99fbf6a6d4c9182c46 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-04 | 176 | 118 | 5 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-04 | 177 | 118 | 5 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.12e-04 | 178 | 118 | 5 | d9142151819afb0dc22bfb32a9c9dba5f553067d | |
| ToppCell | lung|World / shred on tissue and cell subclass | 1.12e-04 | 178 | 118 | 5 | 7b1e371272328d6b6c3994382d64281ffc737db2 | |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.12e-04 | 178 | 118 | 5 | 611504b0a9e6318b18fba83787b03f9245c82252 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 179 | 118 | 5 | fd2cbee532e7b44113410dca82aec7db1a7fb69f | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.18e-04 | 180 | 118 | 5 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.21e-04 | 181 | 118 | 5 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-04 | 182 | 118 | 5 | 8a8b08ac4bb3cba3541dbe234e088703842285b9 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.24e-04 | 182 | 118 | 5 | e36766309c4d96a90d213ce37d3acef1029a3fdc | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 184 | 118 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.30e-04 | 184 | 118 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.30e-04 | 184 | 118 | 5 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 184 | 118 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 184 | 118 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-04 | 185 | 118 | 5 | e9059cefcdf0972ec90793b1dd34c3292b17a061 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.37e-04 | 186 | 118 | 5 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.37e-04 | 186 | 118 | 5 | 77bebf576eb9b96ecb4fefb8a82a31aaaa917fc0 | |
| Drug | LY233536 | 1.11e-06 | 16 | 116 | 4 | CID000126239 | |
| Drug | 7-Cl-Thio-Kyna | 1.45e-06 | 17 | 116 | 4 | CID003035668 | |
| Drug | MNQX | 1.85e-06 | 18 | 116 | 4 | CID000130818 | |
| Drug | 7-chlorokynurenic acid | 3.27e-06 | 45 | 116 | 5 | CID000001884 | |
| Drug | sodium chloride | GPLD1 NEU4 FMO2 MAN2A1 GALM CLEC1B GLB1L2 MFRP ACE SLC3A1 STT3B IGF2R HP PIK3CA MRC2 MMP11 | 8.17e-06 | 865 | 116 | 16 | CID000000206 |
| Drug | L-689,560 | 1.03e-05 | 27 | 116 | 4 | CID000121918 | |
| Drug | AC1NUW3V | 1.38e-05 | 29 | 116 | 4 | CID005462126 | |
| Drug | AC1L32TU | 1.58e-05 | 30 | 116 | 4 | CID000107831 | |
| Drug | NPC 12626 | 1.81e-05 | 31 | 116 | 4 | CID000108099 | |
| Drug | LY235959 | 1.81e-05 | 31 | 116 | 4 | CID000131938 | |
| Drug | eliprodil | 1.81e-05 | 31 | 116 | 4 | CID000060703 | |
| Drug | 1-aminoindan-1,5-dicarboxylic acid | 2.34e-05 | 33 | 116 | 4 | CID000002071 | |
| Drug | 2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid | 2.57e-05 | 2 | 116 | 2 | ctd:C474829 | |
| Drug | 4-bromohomoibotenic acid | 2.57e-05 | 2 | 116 | 2 | ctd:C023366 | |
| Drug | 1NaPP1 | 2.74e-05 | 12 | 116 | 3 | CID000004877 | |
| Drug | C6H12NO5P | 3.32e-05 | 36 | 116 | 4 | CID000104962 | |
| Drug | ibotenic acid | 3.84e-05 | 122 | 116 | 6 | CID000001233 | |
| Drug | GAMs | 4.13e-05 | 38 | 116 | 4 | CID000002935 | |
| Drug | quinoxaline-2,3-dione | 4.50e-05 | 14 | 116 | 3 | CID011469229 | |
| Drug | HA-966 | 4.58e-05 | 39 | 116 | 4 | CID000001232 | |
| Drug | adamantane | 5.60e-05 | 41 | 116 | 4 | CID000009238 | |
| Drug | thiokynurenic acid | 5.61e-05 | 15 | 116 | 3 | CID003035667 | |
| Drug | N,N-dimethylaniline | 6.17e-05 | 42 | 116 | 4 | CID000000949 | |
| Drug | QX-314 | 6.28e-05 | 82 | 116 | 5 | CID000003925 | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; PC3; HT_HG-U133A | 6.65e-05 | 196 | 116 | 7 | 4439_DN | |
| Drug | Etanidazole [22668-01-5]; Up 200; 18.6uM; HL60; HT_HG-U133A | 6.65e-05 | 196 | 116 | 7 | 2510_UP | |
| Drug | Glycopyrrolate [596-51-0]; Down 200; 10uM; PC3; HT_HG-U133A | 7.09e-05 | 198 | 116 | 7 | 3687_DN | |
| Drug | Ethamsylate [2624-44-4]; Down 200; 15.2uM; PC3; HT_HG-U133A | 7.09e-05 | 198 | 116 | 7 | 4576_DN | |
| Drug | Sulfamerazine [127-79-7]; Up 200; 15.2uM; PC3; HT_HG-U133A | 7.32e-05 | 199 | 116 | 7 | 3718_UP | |
| Drug | DL-Serine | 8.29e-05 | 203 | 116 | 7 | CID000000617 | |
| Disease | central nervous system disease (implicated_via_orthology) | 3.11e-05 | 16 | 115 | 3 | DOID:331 (implicated_via_orthology) | |
| Disease | breast angiosarcoma (is_implicated_in) | 4.51e-05 | 3 | 115 | 2 | DOID:4511 (is_implicated_in) | |
| Disease | Hypotonia-Cystinuria Syndrome | 8.99e-05 | 4 | 115 | 2 | C1848030 | |
| Disease | 2p21 microdeletion syndrome | 8.99e-05 | 4 | 115 | 2 | C4304537 | |
| Disease | Schizophrenia | CALB1 ANK3 GRIA1 GRIA2 ACE WDR11 HP PIK3CA NUFIP2 LRP1 FGFR2 HCRTR1 | 1.76e-04 | 883 | 115 | 12 | C0036341 |
| Disease | bilirubin metabolic disorder (biomarker_via_orthology) | 3.12e-04 | 7 | 115 | 2 | DOID:2741 (biomarker_via_orthology) | |
| Disease | sarcoidosis (is_marker_for) | 4.15e-04 | 8 | 115 | 2 | DOID:11335 (is_marker_for) | |
| Disease | ciliopathy (implicated_via_orthology) | 5.13e-04 | 40 | 115 | 3 | DOID:0060340 (implicated_via_orthology) | |
| Disease | HEPATOCELLULAR CARCINOMA | 5.32e-04 | 9 | 115 | 2 | 114550 | |
| Disease | Hepatocellular carcinoma | 5.32e-04 | 9 | 115 | 2 | cv:C2239176 | |
| Disease | Hamartoma Syndrome, Multiple | 5.32e-04 | 9 | 115 | 2 | C0018553 | |
| Disease | Childhood Medulloblastoma | 6.35e-04 | 43 | 115 | 3 | C0278510 | |
| Disease | Melanotic medulloblastoma | 6.35e-04 | 43 | 115 | 3 | C1275668 | |
| Disease | Medullomyoblastoma | 6.35e-04 | 43 | 115 | 3 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 6.35e-04 | 43 | 115 | 3 | C0751291 | |
| Disease | Adult Medulloblastoma | 6.35e-04 | 43 | 115 | 3 | C0278876 | |
| Disease | tooth agenesis (is_implicated_in) | 6.64e-04 | 10 | 115 | 2 | DOID:0050591 (is_implicated_in) | |
| Disease | Head and Neck Carcinoma | 6.64e-04 | 10 | 115 | 2 | C3887461 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 7.32e-04 | 181 | 115 | 5 | DOID:684 (is_implicated_in) | |
| Disease | Gastric cancer | 8.09e-04 | 11 | 115 | 2 | cv:C0024623 | |
| Disease | Neoplasm of stomach | 8.09e-04 | 11 | 115 | 2 | cv:C0038356 | |
| Disease | autosomal recessive polycystic kidney disease (biomarker_via_orthology) | 8.09e-04 | 11 | 115 | 2 | DOID:0110861 (biomarker_via_orthology) | |
| Disease | Congenital long QT syndrome | 8.09e-04 | 11 | 115 | 2 | cv:C1141890 | |
| Disease | Long QT Syndrome | 8.09e-04 | 11 | 115 | 2 | C0023976 | |
| Disease | GASTRIC CANCER | 8.09e-04 | 11 | 115 | 2 | 613659 | |
| Disease | Liver carcinoma | 8.54e-04 | 507 | 115 | 8 | C2239176 | |
| Disease | Long QT syndrome | 9.69e-04 | 12 | 115 | 2 | cv:C0023976 | |
| Disease | Medulloblastoma | 9.89e-04 | 50 | 115 | 3 | C0025149 | |
| Disease | stroke outcome severity measurement | 1.05e-03 | 114 | 115 | 4 | EFO_0009603 | |
| Disease | Fetal Alcohol Spectrum Disorders | 1.14e-03 | 13 | 115 | 2 | C2985290 | |
| Disease | Polydactyly | 1.16e-03 | 117 | 115 | 4 | C0152427 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.30e-03 | 206 | 115 | 5 | C0152013 | |
| Disease | Withdrawal Symptoms | 1.52e-03 | 58 | 115 | 3 | C0087169 | |
| Disease | Drug Withdrawal Symptoms | 1.52e-03 | 58 | 115 | 3 | C0086189 | |
| Disease | Substance Withdrawal Syndrome | 1.52e-03 | 58 | 115 | 3 | C0038587 | |
| Disease | Romano-Ward Syndrome | 1.74e-03 | 16 | 115 | 2 | C0035828 | |
| Disease | cathepsin L1 measurement | 1.74e-03 | 16 | 115 | 2 | EFO_0010619 | |
| Disease | Benign neoplasm of stomach | 1.97e-03 | 17 | 115 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.97e-03 | 17 | 115 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.97e-03 | 17 | 115 | 2 | C0154060 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 1.97e-03 | 17 | 115 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | Fetal Alcohol Syndrome | 1.97e-03 | 17 | 115 | 2 | C0015923 | |
| Disease | breast carcinoma (is_marker_for) | 2.21e-03 | 66 | 115 | 3 | DOID:3459 (is_marker_for) | |
| Disease | Hemangiosarcoma | 2.21e-03 | 18 | 115 | 2 | C0018923 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 2.54e-03 | 145 | 115 | 4 | DOID:1289 (implicated_via_orthology) | |
| Disease | stomach cancer (is_implicated_in) | 2.83e-03 | 72 | 115 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | Stomach Carcinoma | 3.01e-03 | 21 | 115 | 2 | C0699791 | |
| Disease | Paroxysmal atrial fibrillation | 3.30e-03 | 156 | 115 | 4 | C0235480 | |
| Disease | familial atrial fibrillation | 3.30e-03 | 156 | 115 | 4 | C3468561 | |
| Disease | Non-Small Cell Lung Carcinoma | 3.30e-03 | 156 | 115 | 4 | C0007131 | |
| Disease | Persistent atrial fibrillation | 3.30e-03 | 156 | 115 | 4 | C2585653 | |
| Disease | colorectal carcinoma (is_implicated_in) | 3.31e-03 | 22 | 115 | 2 | DOID:0080199 (is_implicated_in) | |
| Disease | ATRIAL FIBRILLATION, FAMILIAL, 1 (disorder) | 3.31e-03 | 22 | 115 | 2 | C1843687 | |
| Disease | Atrial Fibrillation | 3.61e-03 | 160 | 115 | 4 | C0004238 | |
| Disease | Ovarian Serous Adenocarcinoma | 3.61e-03 | 23 | 115 | 2 | C1335177 | |
| Disease | epilepsy (implicated_via_orthology) | 3.86e-03 | 163 | 115 | 4 | DOID:1826 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TWTIYFEGADYESHL | 976 | P55196 | |
| FSDTWNAFTDYDVIH | 286 | Q5NDL2 | |
| SWDVTYSHEVYFDRD | 471 | Q5H9S7 | |
| DGREVVCHASAWDFY | 951 | P12821 | |
| AEAFTGDTYVAASRW | 1066 | Q8N7X0 | |
| HFGYEPLFSWEDSRT | 341 | Q9H2F3 | |
| WSTGLEDTDDSHLYF | 211 | Q7Z2Z2 | |
| FWNSASFDTEASYLH | 791 | Q9C0A0 | |
| FPDVGTYEDFHTIDW | 21 | P51793 | |
| FEIWDTAGQERYHSL | 71 | P20339 | |
| FEIWDTAGQERYHSL | 71 | P61020 | |
| HFRTLVSGFYFWEAA | 6 | O75311 | |
| GDSRWVTTLHYAFQD | 126 | Q6DT37 | |
| GNFHFEEGTRSDDWF | 391 | Q6ZRR7 | |
| VSDSSVEGFGFHAWY | 236 | Q9BY79 | |
| THASGEAWRTFIYGF | 1241 | O75140 | |
| FDRVYTHQSDVWSFG | 676 | P21802 | |
| FWCRDFTAHTGYEVL | 11 | O43586 | |
| FIYDVSFWSFDECHP | 401 | Q15058 | |
| DYLRVSWVHATGDFD | 746 | P23467 | |
| GSAFAVHDLEEDTWY | 356 | P00738 | |
| GDFFTYADRDDHYWS | 491 | Q16706 | |
| FDWGYEERSGAHSSA | 166 | P18615 | |
| RYEGFENDASHDFWC | 246 | Q969R5 | |
| FSHVEGWSFSEGFYF | 191 | Q96T55 | |
| FSGEFDHAWNAVYLE | 261 | Q8NBH2 | |
| VSVFEDFIYWSDRTH | 2101 | Q07954 | |
| DFIYWSDRTHANGSI | 2106 | Q07954 | |
| WSFVSDFAVRDYSGT | 2796 | Q5SZK8 | |
| GDWKAVHDFYLTTFD | 146 | Q5U5R9 | |
| EFSWHLSGEYQRSSD | 486 | Q96KR4 | |
| EAYGSDFWKSVHFTD | 266 | Q8NFR9 | |
| VYFSAFLEAHWTRSS | 471 | Q9P1W3 | |
| RFSPYEWHTEEFEDG | 566 | P42262 | |
| SHASDDYEAWADFRG | 236 | A8MYZ6 | |
| VDFVFSHGLIYWSDV | 56 | O75581 | |
| NVWDFAGREEFYSTH | 1391 | Q5S007 | |
| WSDGVGFSYHNFDRS | 761 | Q9UBG0 | |
| GDTGWDVFSLDYHVD | 631 | Q96CW5 | |
| WKFSDHTEEGRASIY | 41 | O60774 | |
| HSFAFYSDDHGRTWR | 196 | Q8WWR8 | |
| YHFEYTECDSSGSRW | 66 | A8MWY0 | |
| WDCGFEERVFSAYHS | 256 | P46093 | |
| WADAYPFAQHFSEAS | 171 | P22557 | |
| ANWSVSREAGFSYSH | 496 | P42336 | |
| SFFDVTYRHFFGRTW | 61 | O75161 | |
| WYRSAFHSTETIVDG | 366 | Q9HB29 | |
| SDREAVYACFTFSHW | 331 | O43613 | |
| TEDRETVYAWFTFSH | 336 | O43614 | |
| RPGEEYDHTTWFKFS | 326 | Q96C23 | |
| SYKPEFHSDDSWVEF | 331 | P10912 | |
| YYSAFFEAHWTRSGE | 496 | Q5T3F8 | |
| TWRKYDTDHSGFIET | 106 | P05937 | |
| VTGFFDAHVEFTAGW | 241 | Q6IS24 | |
| FTREFDSDSLRHYSW | 951 | Q12955 | |
| SEAFHWDERGRAAAY | 56 | Q96BM1 | |
| SEYVAEHWAEDTFFG | 251 | O75342 | |
| GDFFSYADREDHYWT | 491 | P49641 | |
| ATFTDRSDTFYGHWR | 396 | A6NK06 | |
| EDGYPWDSVFHTRFR | 226 | Q99518 | |
| LEDSTFWIFGGSIHY | 56 | Q8IW92 | |
| TLVREYFSWEGAFQH | 411 | P26641 | |
| LVSRFSPYEWHSEEF | 556 | P42261 | |
| GTFASVEQFWRFYSH | 86 | O60573 | |
| DGEFWMSFSDFLRHY | 321 | P17655 | |
| DATWGHQFCSFSDYD | 461 | Q66K64 | |
| CFWDADTDNYTHDVF | 111 | Q8WW35 | |
| EHERSTAYGWVSATF | 161 | Q5SR56 | |
| GWGAVYTLSEFTHRF | 186 | Q96HA8 | |
| SPRYFFHDAINWGES | 61 | Q3ZCN5 | |
| EFTFEGFSIFEWHHR | 11 | P0C629 | |
| HREGDVHFDYDETWT | 186 | P24347 | |
| GFRFGTVWESSAEAY | 691 | O60391 | |
| AFDVSWFAVHSFGLD | 726 | Q9P2B2 | |
| FYEFEWHTAAACVLS | 606 | P11717 | |
| TFRAQDYTWEDHGYS | 336 | P58004 | |
| LWDTYQSEPEGFSHF | 426 | Q9NU19 | |
| ETSWALGAIFHYIDS | 461 | O75354 | |
| EEGWEYDTFGSKFHL | 976 | A0AVI2 | |
| IWFHSAEAQDSGFYT | 101 | Q9NP60 | |
| FDQDWASGRITRHSY | 796 | Q9Y6C5 | |
| VYDDGTNTFFWRAHT | 51 | Q9BVG9 | |
| SSCFGFEDLHFRWTY | 56 | Q8IWT1 | |
| FEDLHFRWTYNSSDA | 61 | Q8IWT1 | |
| ENPDHGYTSFDSFAW | 346 | Q14524 | |
| HEEPESFFTWFTDHS | 206 | P0DME0 | |
| SFFTWFTDHSDAGAD | 211 | P0DME0 | |
| HEEPESFFTWFTDHS | 196 | Q01105 | |
| SFFTWFTDHSDAGAD | 201 | Q01105 | |
| LSVYGNSSWHFDEVR | 256 | Q07837 | |
| QSGHWSEYFRNFVDS | 246 | Q9UL54 | |
| EDWSFFAVYDGHAGS | 51 | O75688 | |
| DHFLYWGEVSRSLED | 71 | Q9NRY4 | |
| DSCYGFFRHNLTWEE | 111 | Q9P126 | |
| SFRWATGEHQAFTSF | 381 | A5D8T8 | |
| SFRWATGEHQAFTSF | 381 | Q6UXF7 | |
| SFRWATGEHQAFTSF | 381 | Q8NCF0 | |
| EGIWTYTFVFSHGDL | 401 | Q7RTR0 | |
| AESFTSGRHYWEVDV | 296 | Q8N7C3 | |
| SRDYDVEWGYAFDVH | 146 | Q53HI1 | |
| HSHVVRYFSAWAEDD | 356 | P30291 | |
| GTRFSEAWEYFHLAP | 51 | Q9BTP6 | |
| DSWGSFDLRAAIVYH | 651 | Q7Z417 | |
| EVHITFDGWSGAFDY | 201 | Q9UQR0 | |
| SHGFYEFLNWFDERA | 116 | Q8TCJ2 | |
| EALTSYSHRVFSAWD | 286 | Q7Z404 | |
| EGSVWEAFAFASHYN | 161 | Q9H0I9 | |
| VRGEEDFSWFGYSLH | 571 | P80108 | |
| DFSWFGYSLHGVTVD | 576 | P80108 | |
| VFSFRWFVHDFSTED | 161 | Q5GH76 | |
| RESETFVGDYTLSFW | 586 | P19174 | |
| VWGYFEDALSHISRT | 841 | Q8IYF3 | |
| CEDEWESRFYFHPIS | 446 | O43516 | |
| DWGVVFYSVEFSAHS | 976 | P08922 | |
| YRAADSSFWEIADHG | 96 | O95988 | |
| QFHAFISYSEHDSAW | 641 | Q9Y2C9 | |
| FGVFVRYDFEADAHW | 26 | Q9UBD6 | |
| YQSIATHSARDWEAF | 416 | Q8WU66 | |
| IATSGAYDWEFFSVG | 471 | Q8WU66 | |
| LAYHDVFAWSGIAES | 1541 | Q70CQ2 | |
| VSRLYGDESELHFWT | 916 | Q9BZH6 | |
| GADYRWSFDETVTHF | 931 | Q92547 | |
| WSFDETVTHFIYQGR | 936 | Q92547 | |
| SWYSQSFGLHFSLRE | 486 | Q9UGI0 | |
| FTAASHVVFAELYWD | 406 | Q5FWF4 |